Showing posts with label c.diff. Show all posts
Showing posts with label c.diff. Show all posts

Thursday 30 August 2012

Vitamin B3 'helps kill superbugs'????


Vitamin B3 'helps kill superbugs'


Drug-resistant MRSAAntibiotic resistance is increasing

Related Stories

Vitamin B3 could be the new weapon in the fight against superbugs such as MRSA, researchers have suggested.
US experts found B3, also known as nicotinamide, boosts the ability of immune cells to kill Staphylococcus bacteria.
B3 increases the numbers and efficacy of neutrophils, white blood cells that can kill and eat harmful bugs.
The study, in the Journal of Clinical Investigation, could lead to a "major change in treatment", a UK expert said.
B3 was tested on Staphylococcal infections, such as the potentially fatal MRSA (Methicillin-resistant Staphylococcus aureus).
Such infections are found in hospitals and nursing homes, but are also on the rise in prisons, the military and among athletes.
'Turn on'
The scientists used extremely high doses of B3 - far higher than that obtained from dietary sources - in their tests, carried out both on animals and on human blood.

Start Quote

I cannot see why this couldn't be used straight away in infected patients”
Prof Mark Enright,University of Bath
And the researchers say there is as yet no evidence that dietary B3 or supplements could prevent or treat bacterial infections.
The researchers say B3 appears to be able to "turn on" certain antimicrobial genes, boosting the immune cells' killing power.
Prof Adrian Gombart, of Oregon State University's Linus Pauling Institute, who worked on the research, said: "This is potentially very significant, although we still need to do human studies.
"Antibiotics are wonder drugs, but they face increasing problems with resistance by various types of bacteria, especially Staphylococcus aureus.
"This could give us a new way to treat Staph infections that can be deadly, and might be used in combination with current antibiotics.
"It's a way to tap into the power of the innate immune system and stimulate it to provide a more powerful and natural immune response."
Prof Mark Enright, of the University of Bath, said: "Neutrophils are really the front line against infections in the blood and the use of nicotinamide seems safe at this dose to use in patients as it is already licensed for use.
"This could cause a major change in treatment for infections alongside conventional antibiotics to help bolster patients immune system.
"I would like to see in patient clinical trials but cannot see why this couldn't be used straight away in infected patients."

More on This Story

Related Stories

Vitamin B3 (Niacin)


Vitamin B3 (Niacin)

Overview:

Vitamin
B3 is one of 8 B vitamins. It is also known as niacin (nicotinic acid) and has 2 other forms, niacinamide (nicotinamide) and inositol hexanicotinate, which have different effects from niacin.
All B vitamins help the body to convert food (carbohydrates) into fuel (glucose), which is used to produce energy. These B vitamins, often referred to as B complex vitamins, also help the body use fats and protein. B complex vitamins are needed for healthy skin, hair, eyes, and liver. They also help the nervous system function properly.
Niacin also helps the body make various sex and stress-related hormones in the adrenal glands and other parts of the body. Niacin helps improve circulation.
All the B vitamins are water-soluble, meaning that the body does not store them.
You can meet all of your body's needs for B3 through diet. It is rare for anyone in the developed world to have a B3 deficiency. In the United States, alcoholism is the main cause of vitamin B3 deficiency.
Symptoms of mild deficiency include indigestion, fatigue, canker sores, vomiting, and depression. Severe deficiency can cause a condition known as pellagra. Pellagra is characterized by cracked, scaly skin, dementia, and diarrhea. It is generally treated with a nutritionally balanced diet and niacin supplements. Niacin deficiency also causes burning in the mouth and a swollen, bright red tongue.
Very high doses of B3, available by prescription, have been studied to prevent or improve symptoms of the following conditions. However, at high doses niacin can be toxic. You should not take doses higher than the Recommended Daily Allowance except under your doctor's supervision. Researchers are trying to determine if inositol hexanicotinate has similar benefits without serious side effects, but so far results are preliminary.
High Cholesterol
Niacin -- but not niacinamide -- has been used since the 1950s to try to lower elevated LDL ("bad") cholesterol and triglyceride (fat) levels in the blood. However, side effects can be unpleasant and even dangerous. High doses of niacin cause flushing of the skin, stomach upset (which usually subsides within a few weeks), headache, dizziness, and blurred vision. There is an increased risk of liver damage. A time-release form of niacin reduces flushing, but its long-term use is associated with liver damage. In addition, niacin can interact with other cholesterol-lowering drugs (see "Possible Interactions"). You should not take niacin at high doses without your doctor's supervision.
Atherosclerosis and Heart Disease
In one study, men with existing heart disease slowed down the progression of atherosclerosis by taking niacin along with colestipol. They had fewer heart attacks and deaths, as well.
In another study, people with heart disease and high cholesterol who took niacin along with simvastatin (Zocor) had a lower risk of having a first heart attack or stroke. Their risk of death was also lower. In another study, men who took niacin alone seemed to reduce the risk of having a second heart attack, although it did not reduce the risk of death.
Diabetes
Some evidence suggests that niacinamide (but not niacin) might help delay the time that you would need to take insulin in type 1 diabetes. In type 1 diabetes, the body's immune system mistakenly attacks the cells in the pancreas that make insulin, eventually destroying them. Niacinamide may help protect those cells for a time, but more research is needed to tell for sure.
Researchers have also looked at whether high-dose niacinamide might reduce the risk of type 1 diabetes in children at risk for the disease. One study found that it did, but another, larger study found it did not protect against developing type 1 diabetes. More research is needed to know for sure.
The effect of niacin on type 2 diabetes is more complicated. People with type 2 diabetes often have high levels of fats and cholesterol in the blood. Niacin, often along with other drugs, can lower those levels. However, niacin may also raise blood sugar levels, which is particularly dangerous for someone with diabetes. For that reason, anyone with diabetes should take niacin only when directed to do so by their doctor, and should be carefully monitored for high blood sugar.
Osteoarthritis
One preliminary study suggested that niacinamide may improve arthritis symptoms, including increasing joint mobility and reducing the amount of nonsteroidal anti-inflammatory drugs (NSAIDs) needed. More research is needed.
Other
Alzheimer's disease -- Population studies show that people who get higher levels of niacin in their diet have a lower risk of Alzheimer's disease. No studies have evaluated niacin supplements, however.
Cataracts -- One large population study found that people who got a lot of niacin in their diets had a lower risk of developing cataracts.
Skin conditions -- Researchers are studying topical forms of niacin as treatments for rosacea, aging, and prevention of skin cancer, although it's too early to know whether it is effective.
Researchers are also studying the use of vitamin B3 in treating ADHD, migraines, dizziness, depression, motion sickness, and alcohol dependence. But there is no evidence that it helps treat any of these conditions.

Dietary Sources:

The best food sources of vitamin B3 are found in beets, brewer's yeast, beef liver, beef kidney, fish, salmon, swordfish, tuna, sunflower seeds, and peanuts. Bread and cereals are usually fortified with niacin. In addition, foods that contain tryptophan, an amino acid the body coverts into niacin, include poultry, red meat, eggs, and dairy products.

Available Forms:

Vitamin B3 is available in several different supplement forms: niacinamide, niacin, and inositol hexaniacinate. Niacin is available as a tablet or capsule in both regular and timed-release forms. The timed-release tablets and capsules may have fewer side effects than regular niacin. However, the timed-release versions are more likely to cause liver damage. Regardless of which form of niacin you're using, doctors recommend periodic liver function tests when using high doses (above 100 mg per day) of niacin.

How to Take It:

Daily recommendations for niacin in the diet of healthy individuals are listed below.
Generally, high doses of niacin are used to control specific diseases. Such high doses must be prescribed by a doctor, who will have you increase the amount of niacin slowly, over the course of 4 - 6 weeks, and take the medicine with meals to avoid stomach irritation.
Pediatric
  • Infants birth - 6 months: 2 mg (adequate intake)
  • Infants 7 months - 1 year: 4 mg (adequate intake)
  • Children 1- 3 years: 6 mg (RDA)
  • Children 4 - 8 years: 8 mg (RDA)
  • Children 9 - 13 years: 12 mg (RDA)
  • Boys 14 - 18 years: 16 mg (RDA)
  • Girls 14 - 18 years: 14 mg (RDA)
Adult
  • Men 19 years and older: 16 mg (RDA)
  • Women 19 years and older: 14 mg (RDA)
  • Pregnant women: 18 mg (RDA)
  • Breastfeeding women: 17 mg (RDA)

Precautions:

Because of the potential for side effects and interactions with medications, you should take dietary supplements only under the supervision of a knowledgeable health care provider.
High doses (50 mg or more) of niacin can cause side effects. The most common side effect is called "niacin flush," which is a burning, tingling sensation in the face and chest, and red or flushed skin. Taking an aspirin 30 minutes prior to the niacin may help reduce this symptom.
At the very high doses used to lower cholesterol and treat other conditions, liver damage and stomach ulcers can occur. Your health care provider will regularly check your liver function through a blood test.
People with a history of liver disease, kidney disease, or stomach ulcers should not take niacin supplements. Those with diabetes or gallbladder disease should do so only under the close supervision of their doctor.
Stop taking niacin or niacinamide at least two weeks before a scheduled surgery.
Niacin and niacinamide may make allergies worse by increasing histamine.
People with low blood pressure should not take niacin or niacinamide because they may cause a dangerous drop in blood pressure. Don' t take niacin if you have a history of gout.
People with coronary artery disease or unstable angina should not take niacin without their doctor' s supervision, as large doses can raise the risk of heart rhythm problems.
Taking any one of the B vitamins for a long period of time can result in an imbalance of other important B vitamins. For this reason, you may want to take a B complex vitamin, which includes all the B vitamins.

Possible Interactions:

If you are currently taking any of the following medications, you should not use niacin without first talking to your health care provider.
Antibiotics, Tetracycline -- Niacin should not be taken at the same time as the antibiotic tetracycline because it interferes with the absorption and effectiveness of this medication. All vitamin B complex supplements act in this way and should be taken at different times from tetracycline.
Aspirin -- Taking aspirin before taking niacin may reduce flushing from niacin, but take it only under your doctor's supervision.
Anti-seizure Medications -- Phenytoin (Dilantin) and valproic acid (Depakote) may cause niacin deficiency in some people. Taking niacin with carbamazepine (Tegretol) or mysoline (Primidone) may increase levels of these medications in the body.
Anticoagulants (blood thinners) -- Niacin may make the effects of these medications stronger, increasing the risk of bleeding.
Blood Pressure Medications, Alpha-blockers -- Niacin can make the effects of medications taken to lower blood pressure stronger, leading to the risk of low blood pressure.
Cholesterol-lowering Medications -- Niacin binds the cholesterol lowering medications known as bile-acid sequestrants and may make them less effective. For this reason, niacin and these medications should be taken at different times of the day. Bile-acid sequestrants include colestipol (Colestid), colesevelam (Welchol), and cholestyramine (Questran).
Statins -- Some scientific evidence suggests that taking niacin with simvastatin (Zocor) appears to slow down the progression of heart disease. However, the combination may also increase the likelihood for serious side effects, such as muscle inflammation or liver damage.
Diabetes Medications -- Niacin may increase blood sugar levels. People taking insulin, metformin (Glucophage), glyburide (Dibeta, Micronase), glipizide (Glucotrol), or other medications used to treat high blood glucose levels should monitor their blood sugar levels closely when taking niacin supplements.
Isoniazid (INH) -- INH, a medication used to treat tuberculosis, may cause a niacin deficiency.
Nicotine Patches -- Using nicotine patches with niacin may worsen or increase the risk of flushing associated with niacin.
These medications may lower levels of niacin in the body:
  • Azathioprine (Imuran)
  • Chloramphenicol (Chloromycetin)
  • Cycloserine (Seromycin)
  • Fluorouracil
  • Levodopa and carbidopa
  • Mercaptopurine (Purinethol)

Alternative Names:

Inositol hexaniacinate; Niacin; Niacinamide; Nicotinamide; Nicotinic acid
  • Reviewed last on: 8/31/2011
  • A.D.A.M. Editorial Team: David Zieve, MD, MHA, and David R. Eltz. Previously reviewed by Steven D. Ehrlich, NMD, Solutions Acupuncture, a private practice specializing in complementary and alternative medicine, Phoenix, AZ. Review provided by VeriMed Healthcare Network (6/12/2011).

Supporting Research

AIM-HIGH Investigators. The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol Rationale and study design. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: Impact on Global Health outcomes (AIM-HIGH). Am Heart J. 2011 Mar;161(3):471-477.e2.
Bissett DL, Oblong JE, Berge CA, et al. Niacinamide: A B vitamin that improves aging facial skin appearance. Dermatol Surg. 2005;31:860-865; discussion 865.
Brown BG, Zhao XQ, Chalt A, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med. 2001;345(22):1583-1592.
Cumming RG, Mitchell P, Smith W. Diet and cataract: the Blue Mountains Eye Study. Ophthalmology. 2000;107(3):450-456.
Draelos ZD, Ertel K, Berge C, et al. Niacinamide-containing facial moisturizer improves skin barrier and benefits subjects with rosacea. Cutis. 2005;76:135-141.
Elam M, Hunninghake DB, Davis KB, et al. Effects of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: a randomized trial. Arterial Disease Multiple Intervention Trial. JAMA. 2000;284:1263-1270.
Garcia-Closas R. et al. Food, nutrient and heterocyclic amine intake and the risk of bladder cancer. Eur J Cancer. 2007;43(11):1731-40.
Goldberg A, Alagona P, Capuzzi DM, et al. Multiple-dose efficacy and safety of an extended-release form of niacin in management of hyperlipidemia. Am J Cardiol. 2000;85:1100-1105.
Guyton JR. Niacin in cardiovascular prevention: mechanisms, efficacy, and safety. Curr Opin Lipidol. 2007 Aug;18(4):415-20.
Jacques PF, Chylack LT Jr, Hankinson SE, et al. Long-term nutrient intake and early age related nuclear lens opacities. Arch Ophthalmol. 2001;119(7):1009-1019.
Kuzniarz M, Mitchell P, Cumming RG, Flood VM. Use of vitamin supplements and cataract: the Blue Mountains Eye Study. Am J Ophthalmol. 2001;132(1):19-26.
Mittal MK, Florin T, Perrone J, Delgado JH, Osterhoudt KC. Toxicity from the use of niacin to beat urine drug screening. Ann Emerg Med. 2007;50(5):587-90.
Nutrients and Nutritional Agents. In: Kastrup EK, Hines Burnham T, Short RM, et al, eds. Drug Facts and Comparisons. St. Louis, Mo: Facts and Comparisons; 2000:4-5.
Raja R, Thomas JM, Greenhill-Hopper M, Ley SV, Almeida Paz FA. Facile, one-step production of niacin (vitamin B3) and other nitrogen-containing pharmaceutical chemicals with a single-site heterogeneous catalyst. Chemistry. 2008;14(8):2340-8.
Sanyal S, Karas RH, Kuvin JT. Present-day uses of niacin: effects on lipid and non-lipid parameters. Expert Opin Pharmacother. 2007 Aug;8(11):1711-7.
Torkos S. Drug-nutrient interactions: a focus on cholesterol-lowering agents. Int J Integrative Med. 2000;2(3):9-13.
Wolerton: Comprehensive Dermatalogic Drug Therapy, 2nd ed. Philadelphia, PA: Saunders Elsevier. 2007.
Zhao H, Yang X, Zhou R, Yang Y. Study on vitamin B1, vitamin B2 retention factors in vegetables. Wei Sheng Yan Jiu. 2008;37(1):92-6.


Read more: http://www.umm.edu/altmed/articles/vitamin-b3-000335.htm#ixzz2520UrkZZ

Wednesday 22 August 2012

MRSA and C. diff deaths falling


MRSA and C. diff deaths falling

Deaths from MRSA fell by a quarter, from 485 in 2010 to 364 in 2011.
There were 2,053 C. difficile infections last year, compared with 2,704 the year before.
Earlier this year, the Health Protection Agency warned other infections were taking their place.
Both infections have shown large declines over the past five years after being repeatedly targeted by government policies.
MRSAHowever, there is some concern other infections such as E.coli appear to be rising.
The health minister, Simon Burns, said: "The news that MRSA deaths are lower than at any point in the last 15 years is a testament to the hard work and dedication of NHS staff across the country."

Monday 22 August 2011

how the body stops C. diff from being toxic

Gut's hospital bug defence found

Clostridium difficile bacteria Researchers show how the body stops C. diff from being toxic

Related Stories

The way cells in the gut fight off toxins produced by a hospital bug has been discovered by US researchers.

Writing in Nature Medicine, they showed how a chemical - GSNO - deactivated a toxin from Clostridium difficile which causes inflammation and diarrhoea.

They hope to use their findings to develop a treatment for C. difficile.

A specialist in the bacterium said the discovery was "exciting", but any treatment was still a long way off.

C. difficile is one of many bacteria which can live in the human gut without causing health problems.

No competition

Start Quote

Understanding how this mechanism deactivates toxins provides a basis for developing new therapies that can target toxins directly”

End Quote Dr Jonathan Stamler Case Western Reserve University

A course of antibiotics, which wipes out other bacteria in the gut, can allow C. difficile to multiply and run rampant in the bowels.

They produce large numbers of toxins which enter the cells lining the bowel. This damages the cells resulting in inflammation, cramps, fever, diarrhoea and blood-stained stools.

It is particularly a problem in hospitals as the bacteria can spread, and many patients could be taking antibiotics or have a weakened immune system.

In hospitals in England there were 10,414 C. difficile infections during the financial year 2010-11, down from 33,442 in 2007-08.

Access denied

The whole toxin is unable to penetrate cells so it needs to cleave off a smaller chunk.

Scientists have identified the chemical GSNO - S-nitrosoglutathione - which is produced by the bowels in response to inflammation. It can bind to the toxin, preventing cleavage, so the toxin cannot enter cells.

One of the researchers Dr Jonathan Stamler, from the Case Western Reserve University, said: "Understanding how this mechanism deactivates toxins provides a basis for developing new therapies that can target toxins directly and thereby keep bacterial infections, like C. diff, from spreading."

In experiments on mice, the study showed giving the chemical orally increased survival. Researchers now want to begin clinical trials.

The report's lead author Prof Tor Savidge, from the University of Texas, believes the technique could be used on other infections.

"Along with its potential to provide a much-needed new approach to treating Clostridium difficile infection, the discovery could be applied to developing new treatments for other forms of diarrhoea, as well as non-diarrheal diseases caused by bacteria," he said.

Prof Nigel Minton, from the Clostridia Research Group at the University of Nottingham, said: "This is an exciting discovery.

"Anything that can add to our scant arsenal of available treatments for combating this devastating disease is an important step forward.

"Having said that, one imagines that an actual therapeutic based on this discovery is some way off, either from being developed, and more importantly, from entering the clinic."

More on This Story

Related Stories

The BBC is not responsible for the content of external Internet sites

Monday 28 September 2009

Dramatic rise in C. diff deaths

rise in C. diff deaths
image of clostridium
Tackling hospital infections is a top government priority
The number of deaths linked to hospital bug Clostridium difficile has soared in England and Wales, figures from the Office for National Statistics show.

Between 2005 and 2006 the number of death certificates which mentioned the infection rose by 72% to 6,480, most of which were elderly people.

In over half of cases, it was listed as the underlying cause of death.

It is thought that some of the increase may be due to more complete reporting on death certificates.

How numbers have changed

Deaths involving C. difficile increased by 77% in men, and 66% in women between 2005 and 2006.

Since 2006 we have taken significant steps to tackle infections
Professor Brian Duerden, Department of Health

Rates in both sexes have gone up dramatically since 2001, when there were only 1,200 mentions of the infection on death certificates.

The ONS figures also showed deaths involving MRSA remained roughly the same between 2005 and 2006 - at around 1,650.

C. difficile usually affects the elderly, and can prove fatal if antibiotic treatment fails to kill all the spores in the gut, and they take hold again before the patient's own gut bacteria have had chance to mount a resistance.

It is also very difficult to eradicate from the ward environment, which means it is easy for other patients to become infected.

C. diff deaths England and Wales

MRSA figures

Professor Brian Duerden, chief microbiologist at the Department of Health, said in July 2005 they called for more accurate reporting of infections such as MRSA and C. difficile on death certificates.

"These statistics from 2006 show that this move has worked and our figures are now in line with other developed countries.

"Since 2006 we have taken significant steps to tackle infections.

"These include stringent hand-washing guidance for the NHS, a bare below the elbows dress code, putting matrons back in charge of cleanliness on their wards and an ongoing deep clean of every ward."

And he added hospital infection rates were now falling.

The Health Protection Agency reported in November 2007 that rates of C. difficile infection may be levelling off with the number of new cases down 7% to 13,660, while MRSA cases are falling.

Liberal Democrat health spokesman Norman Lamb said: "These figures beg the question of why it took so long for the government to realise the seriousness of deadly infections such as C. difficile.

"Recent successes in keeping infection rates down are down to the hard work of NHS staff, who are up against enormous pressure to hit targets while keeping their wards infection-free."

Shadow health secretary, Andrew Lansley, said: "Almost three times as many people are now killed by hospital infections as are killed on the roads each year.

"The overall scale of infection is unacceptable and the need for a comprehensive infection control strategy, including improved antibiotic prescribing and access to isolation facilities, hand hygiene and cleanliness is paramount."

He added: "An expert told the Department of Health last week that it was the government's failure to implement guidelines since as far back as 1994 that has contributed to the recent rise."

MRSA deaths England and Wales


C. diff rise due to 'gene switch

C. diff rise due to 'gene switch'

Clostridium difficile
Most deaths from C. difficile occur in the over 65s

The rise in Clostridium difficile infections in recent years is due to genetic changes rather than dirty hospitals, say UK researchers.

Comparison of an historic strain and a strain from the outbreak at Stoke Mandeville hospital in 2003 found it had evolved to be more virulent.

It can spread more easily and cause more severe symptoms, the team reports in Genome Biology journal.

NHS trusts have a target to cut C. difficile infections by 30% by 2010/11.

The bacteria are present in the gut of as many as 3% of healthy adults and 66% of infants.

It rarely causes problems in healthy people but can lead to illness when the normal balance of bacteria in the gut is disrupted, for example with use of certain antibiotics, and it is the leading cause of hospital-acquired diarrhoea.

The deep clean programme was never going to work against this organism in the long term
Professor Brendan Wren

In the past five years, a new group of highly virulent C. difficile strains has emerged - PCR-ribotype 027 - which cause more severe diarrhoea and a higher rate of deaths.

Analysis of the full genome of the "hyper-virulent" strains and an older strain showed the bacteria have acquired genes which enable them to survive better in the environment, spread more easily and make patients more severely ill.

In all, five different genetic regions appear to have accumulated in the bacteria in past couple of decades, the team reported in Genome Biology.

Fighting back

The number of cases of C. difficile has risen dramatically since the 1990s, although latest figures show cases are now consistently falling.

Stoke Mandeville Hospital saw two major outbreaks of C. difficile between 2003 and 2006 that caused 35 deaths.

Study leader Professor Brendan Wren, from the London School of Hygiene and Tropical Medicine, said the study would help scientists understand how C. difficile became so aggressive.

"These strains came from nowhere and the sudden rise in C. difficile was due to their spread.

"The bugs are fighting back and the one clear thing that comes out of this study is it is not down to cleaning but that the strain has evolved with new chunks of DNA.

"The deep clean programme was never going to work against this organism in the long term."

Hygiene measures are still needed to keep the infection under control, he added.

A spokeswoman for the Health Protection Agency said it closely monitored the evolution of C. difficile strains.

"All strains of C. difficile require intervention and control - the intervention involved when dealing with the 027 strain is no different than how any other strain is treated.

"All C. difficile requires treatment and vigilant infection control procedures in order to reduce rates of infection."

Featured post

More patients in Scotland given antidepressants

More patients in Scotland given antidepressants 13 October 2015   From the section Scotland Image copyright Thinkstock Image ca...